COMPOUND OYSTER PEPTIDE

Manufacturer
Bispit Canada Ltd.
Effective date
2025-08-03
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:34:36

Label at a glance#

ProductCOMPOUND OYSTER PEPTIDE
Active ingredientLYCIUM CHINENSE FRUIT, ASIAN GINSENG, LICORICE, POLYGONATUM SIBIRICUM WHOLE, PHYLLOLOBIUM CHINENSE SEED, RIBOFLAVIN, ZINC LACTATE, TAURINE, THIAMINE, CORNUS OFFICINALIS WHOLE, SEA CUCUMBER, UNSPECIFIED, DIOSCOREA CAYENENSIS TUBER, WHITE MULBERRY, OYSTER, UNSPECIFIED
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ASIAN GINSENG
LYCIUM CHINENSE FRUIT
POLYGONATUM SIBIRICUM WHOLE
CORNUS OFFICINALIS WHOLE
SEA CUCUMBER, UNSPECIFIED
PHYLLOLOBIUM CHINENSE SEED
WHITE MULBERRY
DIOSCOREA CAYENENSIS TUBER
1EQV5MLY3D
LICORICE
OYSTER
ZINC LACTATE
THIAMINE
RIBOFLAVIN

OTC - PURPOSE SECTION

lmprove Physical EnergyEnhance The Quality Of Sexual Life

WARNINGS SECTION

Not suitable for individuals under 18years of age

Do not use if you have a seafood allergy.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OTC - DO NOT USE SECTION

Do not use if you have a seafood allergy

OTC - WHEN USING SECTION

This productisuatle for men.Longlem use helps nourish the kidneys andal energy enhance physical vigorimprove thequalty of sexualfe,improvemornimg erecions and hardnes,andeeve postcoila
fatigue. This product ispurely derived from botanical extracts,making it suitable for long-term use withno reported adverse side effects.

DOSAGE & ADMINISTRATION SECTION

Dosage:2-4 tablets per day

INDICATIONS & USAGE SECTION

Thisproductisuable for men.Long em use helpsnouish the kidneys antvila energyenhancephyskcal igoimprowve thequalty of sexual le,imprvemornimg erecions and hardnes,andeeve postcoita
fatigue. This product ispurely derived from botanical extracls, making it suitable for long-term use withno reported adverse side effects

INACTIVE INGREDIENT SECTION

CALCIUM CARBONATE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labelinglabeling

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f47a510b-6679-4664-b2d6-47b5c4afe7ccProduct name420260217
cf050ccd-1144-f76a-e00d-e5698d8597d4Product name620250625
030ce964-9b2d-45aa-b5d3-f78ce03ef61cProduct name220250515
0306390c-dd77-4363-afe0-63c58088b2a1Product name120220120
503ea967-4b9c-48cf-9e87-c7975295849dProduct name220220120
190f2a5b-bbc8-65c7-fcb0-97891307b917Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85631-004-01COMPOUND OYSTER PEPTIDE60 in 1 BOTTLECAPSULE601
85631-004-01COMPOUND OYSTER PEPTIDE1.2 g in 1 CAPSULECAPSULE1.21

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85631-00485631-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
COMPOUND OYSTER PEPTIDECOMPOUND OYSTER PEPTIDEBispit Canada Ltd.3b778dc1-d1ac-1415-e063-6394a90aeb392025-08-03WarningsExact identifier
ndc (package): 85631-004-01
ndc (product): 85631-004
ndc11 (package): 85631000401
spl id: 3b778dc1-d1ad-1415-e063-6394a90aeb39
spl set id: 3b778dc1-d1ac-1415-e063-6394a90aeb39

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.